DHODH/IL-17 Inhibitors (Incozen Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDHODH/IL-17 Inhibitors (Incozen Therapeutics)
Drug Alias NameDihydroorotate Dehydrogenase/IL-17 Inhibitors (Incozen Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitorsInterleukin-17 inhibitors
TargetsDihydroorotate dehydrogenaseInterleukin-17
Therapy Area/IndicationsMultiple SclerosisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncozen Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncozen Therapeutics Pvt Ltd
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A